tiprankstipranks
Trending News
More News >

Impedimed Director Increases Shareholding in Company

Story Highlights
  • Impedimed Limited operates in the medical technology industry, offering solutions for fluid status and tissue composition.
  • Director Christine Emmanuel-Donnelly acquired additional shares, indicating confidence in Impedimed’s future.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Impedimed Director Increases Shareholding in Company

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Impedimed Limited ( (AU:IPD) ).

Impedimed Limited announced a change in the director’s interest notice, specifically regarding Ms. Christine Emmanuel-Donnelly’s holdings. The change involved an acquisition of 306,446 ordinary shares in the Donnelly Superannuation Fund, increasing her total holdings in this fund to 1,736,255 shares. This transaction, conducted as an on-market trade, reflects the director’s increased investment in the company, potentially signaling confidence in Impedimed’s future prospects and stability.

The most recent analyst rating on (AU:IPD) stock is a Buy with a A$0.20 price target. To see the full list of analyst forecasts on Impedimed Limited stock, see the AU:IPD Stock Forecast page.

More about Impedimed Limited

Impedimed Limited operates in the medical technology industry, focusing on products that provide non-invasive solutions for measuring, monitoring, and managing fluid status and tissue composition. The company primarily serves healthcare providers and patients, aiming to improve clinical outcomes through its innovative technologies.

Average Trading Volume: 1,423,122

Technical Sentiment Signal: Sell

Current Market Cap: A$60.82M

Find detailed analytics on IPD stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1